CompoundReference
An educational database of performance‑related compounds in fitness and bodybuilding
CompoundReference is an independent reference platform focused on the biological, pharmacological, and research context of compounds commonly discussed in bodybuilding and fitness literature.
Editorial Standards
This section explains how content on CompoundReference is researched, reviewed, and updated.
CompoundReference follows editorial standards that prioritize scientific accuracy, transparency, and neutrality. Content emphasizes peer‑reviewed and clinical research, cites sources transparently, and presents risks, effects, and limitations objectively within a harm‑reduction and legal context.
Our editorial process includes:
- An educational and descriptive scope only – no medical advice, dosing, or protocols
- Mechanistic explanations based on biology and pharmacology
- Use of peer‑reviewed literature, clinical research, and established scientific references
- Clear separation between content authorship and subject‑matter review
- Periodic review to reflect new research and regulatory changes
All content is written to explain how compounds are classified, studied, and discussed, not to influence decisions related to their use.
The platform operates independently of commercial influence: no sponsorships, affiliate links, or product promotion are accepted. Limited advertising may appear; it has no role in editorial decisions.
Anabolic Steroids
Background and classification of anabolic‑androgenic steroids in research contexts.
Anabolic‑androgenic steroids (AAS) are a class of synthetic compounds structurally related to testosterone. In bodybuilding and fitness literature, they are discussed in relation to muscle tissue signaling, androgen receptor interaction, and systemic endocrine effects.
Research Topics Covered:
- Androgen receptor interaction and protein synthesis mechanisms
- Aromatization and estrogen‑related findings
- HPTA suppression and recovery patterns documented in studies
- Hepatic considerations in oral vs. injectable compounds
- Cardiovascular and lipid‑related observations
- Detection and testing windows described in anti‑doping research
Selected steroid compound references:
Testosterone Enanthate
The primary endogenous androgen, widely studied in medical and physiological research for its role in muscle development, secondary sex characteristics, and hormonal regulation.
Anavar (Oxandrolone)
A synthetic anabolic‑androgenic steroid studied for its altered androgenic profile, hepatic metabolism, and tissue‑selective activity in clinical and non‑clinical literature.
Dianabol (Methandrostenolone)
An oral anabolic steroid historically examined for its effects on protein synthesis, nitrogen balance, estrogenic conversion, and systemic endocrine suppression.
SARMs
Overview of selective androgen receptor modulators as described in scientific literature.
Selective androgen receptor modulators (SARMs) are a group of experimental compounds designed to interact with androgen receptors in a more targeted manner than traditional anabolic steroids.
Research Areas Addressed:
- Tissue selectivity theories and documented limitations
- Implications of “research chemical” classification
- Hormonal suppression findings in human studies
- Reported liver enzyme changes
- Gaps in long‑term safety data, regulatory and testing status
Selected SARM compound references:
Ostarine (MK‑2866)
An investigational compound studied for its androgen receptor binding properties and tissue‑selective signaling in clinical research settings.
Testolone (RAD‑140)
A non‑steroidal SARM examined in preclinical studies for its receptor affinity and potential anabolic signaling characteristics.
PCT & Estrogen‑Related Pharmacology
Overview of compounds discussed in hormonal recovery and estrogen‑related research.
A category of pharmaceutical agents and hormonal pathways discussed in clinical and bodybuilding literature in relation to endocrine disruption and recovery following exposure to androgenic or androgen‑modulating compounds.
This section documents how these substances are described in medical research, endocrinology texts, and clinical case literature, without providing treatment guidance or protocols.
Research Topics Covered:
- HPTA suppression and recovery patterns
- Estrogen‑related findings during androgen exposure
- Post‑exposure testosterone dynamics
- Gynecomastia‑related mechanisms
- Lean mass retention observations
Selected PCT compound references:
Clomiphene Citrate (Clomid)
A selective estrogen receptor modulator (SERM) historically prescribed for fertility‑related conditions and discussed in literature examining endocrine feedback mechanisms.
Tamoxifen Citrate (Nolvadex)
A SERM widely studied in oncology and endocrinology, with documented effects on estrogen receptor modulation and hormonal signaling pathways.
Frequently Asked Questions
Answers to common questions about the scope, limitations, and intent of the information presented on this site.
CompoundReference is an educational reference website documenting performance‑related compounds through a research‑based and descriptive framework.
CompoundReference is intended for competitive bodybuilders researching compounds for contest preparation, serious lifters seeking to understand the pharmacology and documented effects of substances before use, and evidence‑based athletes who want to distinguish scientific findings from gym folklore. It also serves fitness professionals who require credible, research‑grounded information when addressing client questions, as well as students and researchers studying sports science, pharmacology, or related fields. Health‑conscious users who are already using or considering the use of compounds can also use this resource to better understand documented health risks and physiological implications.
Content on CompoundReference is grouped into broad research categories that organize related compounds together for clarity and context.
For example, anabolic steroid profiles are collected within the Steroids section, where individual compounds are presented as structured reference profiles focused on documented mechanisms, background, and considerations rather than instructions for use.
All content is developed using a structured, evidence‑based methodology. Research is drawn from peer‑reviewed medical and scientific literature, including clinical pharmacology studies, endocrinology research, and sports medicine publications.
Clinical data such as FDA drug labels, pharmaceutical monographs, clinical trial results, and documented case reports are used to support accuracy and context.
Pharmacological details are referenced from established databases like DrugBank, along with published pharmacokinetic, interaction, and mechanism‑of‑action research.
Regulatory information is sourced from official agencies, including DEA scheduling, WADA prohibited lists, FDA advisories, and international legal classifications.
To maintain credibility and neutrality, anecdotal reports, forum posts, underground lab marketing materials, influencer content without credentials, supplement company claims, and unsourced statements are intentionally excluded.
CompoundReference is an independent educational database that provides scientific and pharmacological information about performance‑enhancing compounds. All content is provided for informational purposes only and does not constitute medical advice, diagnosis, treatment recommendations, dosing guidance, legal advice, or instructions for use. Nothing on this site should be interpreted as encouragement or endorsement of illegal activity.
Some compounds documented on CompoundReference are prescription medications, controlled substances, or associated with significant health risks, including serious injury or death. Many are not approved for performance enhancement, and long‑term safety data may be limited or evolving.
Users are responsible for their own health and legal decisions. Readers should consult qualified medical professionals before using any pharmaceutical compound and ensure compliance with all applicable laws. Information may be incomplete, updated over time, or subject to interpretation.
CompoundReference does not sell, distribute, or facilitate access to any compounds and does not provide sourcing information. In the event of a medical emergency, seek immediate medical attention from local emergency services.
CompoundReference is built around a research‑first approach that prioritizes verified scientific evidence over anecdote or hype. All content is grounded in published studies, established pharmacology, and documented clinical data, with clear explanations of how compounds work, what effects have been observed, and what risks are supported by evidence. Legal and regulatory context is included so readers understand how substances are classified and monitored, and information is updated as new research becomes available. Risk is discussed realistically, without exaggeration or minimization.
At the same time, CompoundReference intentionally avoids providing dosing protocols, cycle designs, sourcing information, or rankings of “best” compounds. It does not promote dramatic claims or sensationalized outcomes, and it does not replace medical guidance. The focus remains on accurate information and documented effects, allowing readers to make informed decisions in consultation with qualified healthcare professionals.
Each compound profile follows a standardized, research‑based structure designed to present information clearly and consistently. Profiles typically include an overview of the compound and its pharmacology, research‑documented effects, known side effects and health risks, interactions and contraindications, and contextual references to how the compound is discussed within bodybuilding communities. Legal and testing status, blood work and health monitoring considerations, research limitations, and fully cited references are also provided to support transparency and informed understanding.
Dosing constitutes medical guidance and varies widely based on individual health factors. This platform does not provide medical advice or personalized recommendations.
Research shows that androgenic compounds may cause virilizing effects in females, some of which may be irreversible. Female‑specific data is limited and warrants careful interpretation.
Disclaimer: This website provides informational and educational content only. Nothing on CompoundReference should be interpreted as medical advice, treatment recommendations, or instructions regarding pharmaceutical substance use.